FN2 Earnings Intelligence

AMETEK, Inc. earnings overview

Latest AMETEK, Inc. (AME) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportAMETEK, Inc. reports Thursday, Oct 29, 2026 · Before market openConsensus EPS $2.11 · consensus revenue $2.12B
AME FY2026 Q2 · Calendar Q3 2026

AMETEK, Inc.

AMETEK's Q2 supports a constructive operating outlook: record sales, sharply higher orders, raised full-year guidance and demand tied to semiconductor, power, defense and MedTech markets. The main test is whether backlog conversion, organic growth and acquisition execution sustain that momentum.

EPS surprise+5.0%
Market move+4.2%
AME FY2026 Q1 · Calendar Q2 2026

AMETEK, Inc.

AMETEK's Q1 FY2026 results reflect broad-based strength, with double-digit organic sales growth, record orders of $2.2 billion, and EBITDA of $620 million. EPS of $1.97 beat the $1.90 consensus by 3.68%, and revenue of $1.93 billion topped estimates by 0.73%. The company raised full-year EPS guidance to $7.94-$8.14 and completed the First Aviation Services acquisition to expand defense MRO capabilities. Management tone was confident, citing robust demand across defense, power, semiconductor, and space markets. The stock rose 3.35% on the report but drifted 4.10% lower subsequently. Prior-quarter comparative analysis was not available.

EPS surprise+3.7%
Market move+3.3%
AME FY2025 Q1 · Calendar Q2 2025

AMETEK, Inc.

The supplied analysis supports a constructive but conditional view: resilient orders, a near-record backlog, new products, and Paragon Medical recovery support the outlook, while tariffs, inventory destocking, and margin execution remain material tests.

EPS surprise—
Market move-1.4%
AME FY2024 Q3 · Calendar Q4 2024

AMETEK, Inc.

AMETEK's Q3 analysis supports a constructive operating trajectory: improving orders, a near-record backlog, acquisitions and product investment accompanied a raised full-year EPS outlook. The case remains dependent on sustained demand and execution through OEM destocking, project delays and regulatory risks.

EPS surprise+2.5%
Market move+8.5%
AME FY2024 Q2 · Calendar Q3 2024

AMETEK, Inc.

AMETEK's earnings support a mixed near-term view: record operating income, margin expansion, and strong cash generation provide resilience, but softer organic demand and lower sales guidance temper the growth outlook. The evidence favors monitoring execution on cost savings, acquisitions, and new programs rather than assuming a smooth recovery.

EPS surprise+1.2%
Market move-8.3%
AME FY2024 Q1 · Calendar Q2 2024

AMETEK, Inc.

The quarter supports a constructive earnings-growth case: record results, higher EPS guidance, margin expansion, pricing above inflation, and acquisition-led growth were balanced by continued destocking and integration risks.

EPS surprise+3.1%
Market move-6.1%

Get the AME recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.